Wall Street expects a year-over-year increase in earnings on higher revenues when Abacus Life, Inc. (ABL) reports results for the quarter ended September 2024. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on November 7, 2024, might help the stock move higher if these key numbers are better ...

ORLANDO, Fla., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leading global alternative asset manager focused on lifespan-based financial products, today announced it will release its Third Quarter 2024 financial results after the market closes on Thursday, November 7, 2024. Abacus will hold a conference call to discuss the financial results at 5:00 pm Eastern Time on November 7, 2024. A live webcast of the conference call will be available on Abacus’ inves ...

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Even ...

Abacus Life, Inc. (ABL) shares ended the last trading session 5.4% higher at $10.40. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 10.1% loss over the past four weeks.ABL stays focused on consolidating its position as a leading market maker and global alternative asset manager.  The strength of partnerships with carriers and reinsurers remains a key contributor to its performance. Also, along with core business o ...

Shares of Abacus Life, Inc. (ABL) have gained 1.9% over the past four weeks to close the last trading session at $10.40, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $14 indicates a potential upside of 34.6%.The mean estimate comprises three short-term price targets with a standard deviation of $2. While the lowest estimate of $12 indicates a 15.4% increase from the current p ...

ORLANDO, Fla., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leading global alternative asset manager focused on lifespan-based financial products, today announced that its popular Abacus Policy Value Calculator, which recently launched its newest generation, has surpassed 150,000 individual submissions from insureds, totaling more than $87 billion in face value. “Since the original version of the calculator, we have been proud to provide over 150,000 insu ...

ORLANDO, Fla., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leading global alternative asset manager focused on lifespan-based financial products, today announced that Corey McLaren has joined Abacus as Managing Director, Capital Markets. Based in Boston, Mr. McLaren has almost two decades of experience in financial services, including over fifteen years of business development and management experience directly related to life settlements. Mr. McLaren mo ...

Abacus Life, Inc. (ABL) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with analysts still raising their earnings estimates for the company.The rising trend in estimate revisions, which is a result of growing analyst optimism on the earnings prospects of this company, should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in ear ...

Shares of Abacus Life, Inc. (ABL) have gained 3.7% over the past four weeks to close the last trading session at $10.30, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $13.67 indicates a potential upside of 32.7%.The average comprises three short-term price targets ranging from a low of $12 to a high of $15, with a standard deviation of $1.53. While the lowest estimate indicate ...

New partnership leverages PREADISAN™, the cutting-edge health prediction platform using machine learning and modern proteomicsApplies novel big data analytics tools to the Abacus portfolio of servicesLorisco's risk scores will enable a more personalized approach to longevity and actuarial technology to maximize value for Abacus’ clients ORLANDO, Fla and NEW YORK, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity an ...